IL164470A0 - Pharmaceutical composition comprising arsenite forthe treatment of malignancy - Google Patents

Pharmaceutical composition comprising arsenite forthe treatment of malignancy

Info

Publication number
IL164470A0
IL164470A0 IL16447002A IL16447002A IL164470A0 IL 164470 A0 IL164470 A0 IL 164470A0 IL 16447002 A IL16447002 A IL 16447002A IL 16447002 A IL16447002 A IL 16447002A IL 164470 A0 IL164470 A0 IL 164470A0
Authority
IL
Israel
Prior art keywords
arsenite
malignancy
pharmaceutical composition
forthe treatment
forthe
Prior art date
Application number
IL16447002A
Other languages
English (en)
Original Assignee
Yong Yin Yang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29244880&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL164470(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yong Yin Yang filed Critical Yong Yin Yang
Publication of IL164470A0 publication Critical patent/IL164470A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL16447002A 2002-04-10 2002-04-10 Pharmaceutical composition comprising arsenite forthe treatment of malignancy IL164470A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2002/000231 WO2003086424A1 (en) 2002-04-10 2002-04-10 Pharmaceutical composition comprising arsenite for the treatment of malignancy

Publications (1)

Publication Number Publication Date
IL164470A0 true IL164470A0 (en) 2005-12-18

Family

ID=29244880

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16447002A IL164470A0 (en) 2002-04-10 2002-04-10 Pharmaceutical composition comprising arsenite forthe treatment of malignancy
IL164470A IL164470A (en) 2002-04-10 2004-10-10 Pharmaceutical composition comprising arsenite for the treatment of solid malignancies

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL164470A IL164470A (en) 2002-04-10 2004-10-10 Pharmaceutical composition comprising arsenite for the treatment of solid malignancies

Country Status (25)

Country Link
US (1) US20050106262A1 (enExample)
EP (2) EP1496918B1 (enExample)
JP (1) JP2005525397A (enExample)
CN (1) CN1298332C (enExample)
AP (1) AP2004003167A0 (enExample)
AU (2) AU2002253713B2 (enExample)
BG (1) BG66356B1 (enExample)
BR (1) BR0215689A (enExample)
CA (1) CA2481602C (enExample)
CY (1) CY1114422T1 (enExample)
DK (2) DK2042182T3 (enExample)
EC (1) ECSP045408A (enExample)
ES (2) ES2944907T3 (enExample)
FI (1) FI1496918T3 (enExample)
HU (1) HU230851B1 (enExample)
IL (2) IL164470A0 (enExample)
LT (1) LT1496918T (enExample)
MX (1) MXPA04009898A (enExample)
NO (1) NO335317B1 (enExample)
NZ (1) NZ536452A (enExample)
PT (2) PT1496918T (enExample)
RO (1) RO123269B1 (enExample)
TN (1) TNSN04198A1 (enExample)
UA (1) UA80426C2 (enExample)
WO (1) WO2003086424A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006024488A2 (en) * 2004-08-30 2006-03-09 Interstitial Therapeutics Medical stent provided with inhibitors of atp synthesis
EP1721615A1 (en) * 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US8945505B2 (en) 2007-02-02 2015-02-03 Panaphix, Inc. Use of arsenic compounds for treatment of pain and inflammation
US20090246291A1 (en) * 2008-03-27 2009-10-01 Angelika Burger Method and compositions for treatment of cancer
US20100249210A1 (en) * 2008-09-30 2010-09-30 Michael Bastiani Methods and compositions related to dlk-1 and the p38 mapk pathway in nerve regeneration
CN102060722B (zh) * 2009-05-01 2014-06-11 常州高新技术产业开发区三维工业技术研究所有限公司 一种含砷化合物及其制备方法和用途
PL2475362T3 (pl) * 2009-09-10 2019-09-30 Kominox, Inc. Terapia celowana w nowotworowe komórki macierzyste i raka lekoopornego
RU2012108439A (ru) * 2009-09-18 2013-10-27 Коминокс, Инк. Способы лечения опухолей головного мозга
CN101695501B (zh) * 2009-10-10 2013-08-14 广汉恒宇新材料有限公司 一种纳米尺寸亚砷酸的壳聚糖包载体及其制造方法
CA3094115A1 (en) 2018-03-22 2019-09-26 Komipharm International Australia Pty Ltd Pharmaceutical composition comprising meta arsenite and method of manufacture

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0804928B1 (en) * 1994-02-18 2004-10-20 Tamara Vasilievna Vorobieva Agent having an immunomodulating effect and reducing disturbed functioning of the tissue cell propagation regulating system
EP1391206B1 (en) * 1997-10-15 2008-07-02 Polarx Biopharmaceuticals, Inc. Pharmaceutical compositions comprising arsenic trioxide for the treatment of non-Hodgkin's lymphoma
CN1119152C (zh) * 1998-08-02 2003-08-27 哈尔滨医科大学第一临床医学院 治疗消化系统肿瘤注射液及其应用

Also Published As

Publication number Publication date
PT1496918T (pt) 2023-05-25
BG66356B1 (bg) 2013-09-30
CY1114422T1 (el) 2016-08-31
DK2042182T3 (da) 2013-08-26
DK1496918T3 (da) 2023-05-15
AU2008255139B2 (en) 2013-10-03
CN1625407A (zh) 2005-06-08
HUP0500199A2 (en) 2007-02-28
PT2042182E (pt) 2013-08-28
ES2944907T3 (es) 2023-06-27
EP1496918A1 (en) 2005-01-19
AP2004003167A0 (en) 2004-12-31
AU2002253713B2 (en) 2008-09-18
ECSP045408A (es) 2006-03-01
BR0215689A (pt) 2005-02-01
EP1496918B1 (en) 2023-02-08
NZ536452A (en) 2007-06-29
JP2005525397A (ja) 2005-08-25
IL164470A (en) 2010-12-30
CN1298332C (zh) 2007-02-07
BG108932A (en) 2005-11-30
TNSN04198A1 (en) 2007-03-12
WO2003086424A1 (en) 2003-10-23
RO123269B1 (ro) 2011-05-30
UA80426C2 (en) 2007-09-25
CA2481602C (en) 2011-06-21
ES2425418T3 (es) 2013-10-15
US20050106262A1 (en) 2005-05-19
AU2002253713A1 (en) 2003-10-27
EP2042182A1 (en) 2009-04-01
CA2481602A1 (en) 2003-10-23
LT1496918T (lt) 2023-05-25
NO20044573L (no) 2004-10-22
NO335317B1 (no) 2014-11-10
MXPA04009898A (es) 2005-06-20
FI1496918T3 (fi) 2023-05-11
AU2008255139A1 (en) 2009-01-08
HUP0500199A3 (en) 2008-03-28
EP2042182B1 (en) 2013-05-22
HU230851B1 (en) 2018-09-28

Similar Documents

Publication Publication Date Title
PL375532A1 (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
CY2015003I1 (el) Φαρμακευτικες συνθεσεις για θεραπεια καρκινου
IL164599A0 (en) Combination therapy for the treatment of cancer
GB0201850D0 (en) Therapeutic treatment
EP1567158A4 (en) METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR TREATING AND CONTROLLING CANCERS AND OTHER DISEASES
GB0216321D0 (en) Therapeutic treatment
IL164896A (en) Pharmaceutical compositions comprising immunoconjugates for the treatment of tumors
AU2003212634A8 (en) Compounds useful in the treatment of cancer
GB0320238D0 (en) Treatment of disease
GB0223367D0 (en) Therapeutic treatment
IL165839A0 (en) Compounds useful for the treatment of cancer compositions thereof and methods therewith
HUP0500199A3 (en) Pharmaceutical composition comprising arsenite for the treatment of malignancy
GB0223854D0 (en) Therapeutic treatment
IL166062A0 (en) Compositions and methods for therapeutic treatment
GB0210464D0 (en) Therapeutic treatment
AU2003270202A8 (en) Pharmaceutical compositions useful for the treatment of cancers
ZA200500431B (en) Medicinal composition for treating arteriosclerosis
AU2003231803A8 (en) Treatment of cancer with mefloquire
GB0329416D0 (en) Treatment of cancer
AU2003240174A8 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
AU2003252185A8 (en) Topical composition for the treatment of scar tissue
HK1077495A (zh) 治疗恶性肿瘤的包含亚砷酸盐的药物组合物
GB2383538B (en) Cancer treatment
GB0229986D0 (en) Treatment of materials
SI2105135T1 (sl) Farmacevtski sestavki za zdravljenje raka